Titel

Merkliste
1 Ergebnisse

Leritrelvir for the treatment of mild or moderate COVID-19 ..:

Yangqing Zhan ; Zhengshi Lin ; Jingyi Liang...
http://www.sciencedirect.com/science/article/pii/S2589537023005369. , 2024

Link: https://doi.org/10.1016/j.eclinm.2023.102359

RT Journal
T1 <Title>Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialResearch in context</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:47dbfffb279a4d67b276d3a4042f438c&Exemplar=1&LAN=DE
				
A1 Yangqing Zhan
A1 Zhengshi Lin
A1 Jingyi Liang
A1 Ruilin Sun
A1 Yueping Li
A1 Bingliang Lin
A1 Fangqi Ge
A1 Ling Lin
A1 Hongzhou Lu
A1 Liang Su
A1 Tianxin Xiang
A1 Hongqiu Pan
A1 Chaolin Huang
A1 Ying Deng
A1 Furong Wang
A1 Ruhong Xu
A1 Dexiong Chen
A1 Ping Zhang
A1 Jianlin Tong
A1 Xifu Wang
A1 Qingwei Meng
A1 Zhigang Zheng
A1 Shuqiang Ou
A1 Xiaoyun Guo
A1 Herui Yao
A1 Tao Yu
A1 Weiyang Li
A1 Yu Zhang
A1 Mei Jiang
A1 Zhonghao Fang
A1 Yudi Song
A1 Ruifeng Chen
A1 Jincan Luo
A1 Changyuan Kang
A1 Shiwei Liang
A1 Haijun Li
A1 Jingping Zheng
A1 Nanshan Zhong
A1 Zifeng Yang
A1 Huang Yanming, M.M
A1 Dong Haiping, M.D
A1 Jinlin Hou, M.M
A1 Shao Lei, M.D
A1 Li Xiaoguang, M.D
A1 Gao Yan, M.M
PB Elsevier
YR 2024
K1 Anti SARS-CoV-2 drug
K1 Mono-therapy
K1 COVID-19
K1 Drug-drug interaction
K1 RCT
K1 Medicine (General)
K1 R5-920
JF http://www.sciencedirect.com/science/article/pii/S2589537023005369
LK http://dx.doi.org/https://doi.org/10.1016/j.eclinm.2023.102359
DO https://doi.org/10.1016/j.eclinm.2023.102359
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)